CN107823424A - 一种治疗慢性咽炎的中药组合物及其制备方法 - Google Patents
一种治疗慢性咽炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN107823424A CN107823424A CN201711253634.8A CN201711253634A CN107823424A CN 107823424 A CN107823424 A CN 107823424A CN 201711253634 A CN201711253634 A CN 201711253634A CN 107823424 A CN107823424 A CN 107823424A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 106
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 201000007100 Pharyngitis Diseases 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract description 29
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 27
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 27
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 26
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 26
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 26
- 241000736199 Paeonia Species 0.000 claims abstract description 26
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 26
- 240000005001 Paeonia suffruticosa Species 0.000 claims abstract description 26
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims abstract description 26
- 241000405414 Rehmannia Species 0.000 claims abstract description 26
- 240000004980 Rheum officinale Species 0.000 claims abstract description 26
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 26
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 238000011282 treatment Methods 0.000 claims description 42
- 230000001954 sterilising effect Effects 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000007654 immersion Methods 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 24
- 210000004072 lung Anatomy 0.000 abstract description 19
- 231100000331 toxic Toxicity 0.000 abstract description 8
- 230000002588 toxic effect Effects 0.000 abstract description 8
- 238000001816 cooling Methods 0.000 abstract description 7
- 241000721047 Danaus plexippus Species 0.000 abstract description 6
- 210000001124 body fluid Anatomy 0.000 abstract description 4
- 239000010839 body fluid Substances 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000000202 analgesic effect Effects 0.000 abstract description 2
- 230000000593 degrading effect Effects 0.000 abstract description 2
- 206010011224 Cough Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000003800 pharynx Anatomy 0.000 description 15
- 206010013789 Dry throat Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000010926 purge Methods 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002075 main ingredient Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010013952 Dysphonia Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000003325 follicular Effects 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000476 body water Anatomy 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 208000027744 congestion Diseases 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 240000003582 Platycodon grandiflorus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021282 Sterculia Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000010550 acute laryngitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003457 anti-vomiting effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 229940059107 sterculia Drugs 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004781 supercooling Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗慢性咽炎的中药组合物及其制备方法,其特征在于本中药组合物由以下重量份的原料组成:生地10‑20份、麦冬10‑15份、玄参10‑15份、川贝母10‑20份、丹皮10‑15份、白芍10‑20份、薄荷10‑15份、黄连8‑15份、黄芩10‑20份、大黄6‑12份、甘草6‑9份;本发明以清热凉血、养阴生津的生地为君药,以麦冬和玄参为臣药,以川贝母、丹皮、白芍、薄荷、黄连、黄芩、大黄为佐药,以甘草为使药,配伍合理,滋阴降火、清热润肺、宣散风热与寒湿、通经络、止痛,无毒副作用,对于各种原因引起的久治不愈的慢性咽炎,疗效好,见效快。
Description
技术领域
本发明专利涉及一种中药,尤其是一种治疗慢性咽炎的中药组合物及其制备方法,属于中药技术领域。
背景技术
慢性咽炎系咽粘膜的慢性炎症。常为呼吸道慢性炎症的一部分。以咽部不适,发干、异物感或轻度疼痛、干咳、恶心,咽部充血呈暗红色,咽后壁可见淋巴滤泡等为主要临床表现。慢性咽炎患者,因咽分泌物增多,故常有清噪动作,吐白色痰液。本病多见,病程长,症状顽固,治疗困难。慢性咽炎患者会经常感到咽部不适,如果遇到情绪不佳、过度劳累、或讲话太多、较长时间不喝水以及身体受寒,都会使咽痛、咽部灼热感加重,还会因咽痒引起阵阵刺激性咳嗽,影响休息。慢性咽炎若感染向上蔓延,波及耳、鼻,可导致急性鼻炎、鼻窦炎,急性中耳炎;向下发展,可侵犯喉、气管等下呼吸道,引起急性喉炎、气管炎、支气管炎及肺炎;若致病菌及毒素侵入血液循环,则可引起全身并发症,如急性肾炎、脓毒血症、风湿病等,对身体危害极大。
中医认为,咽喉是十二经脉必经之路和汇聚的重要部位,能够通过诸经络与相应的脏腑相联系。因此,脏腑功能的失调也会引起咽喉的不适。在临床中观察到,慢性咽炎虽为局部病变,但与全身情况关系密切。所以在治疗方面可以选择含有黄芩、西青果、桔梗、竹茹、胖大海、橘红、枳壳、桑叶等成分的药物比如慢严舒柠清喉利咽颗粒。以起到宽胸理气、调节脏腑功能,从而达到调节机体代谢功能,增强机体免疫力的作用。但是,目前并没有能够针对久治不愈的慢性咽炎起到根治作用的药物,大多数药物只能控制病情,容易反复,不能治愈。所以,针对现有的病理机制和理法方药,有待进一步提高认识,改进和完善治疗慢性咽炎的中药组合物。
发明内容
针对现有技术中的问题,本发明的目的是要提供一种治疗慢性咽炎的中药组合物及其制备方法,通过该方法制备的中药组合物安全可靠,无毒副作用,见效快,价格低廉,结合君臣佐使配药机理进行配伍,对慢性咽炎具有很好的疗效。
为了达到上述目的,本发明的技术方案是:
一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成:生地10-20份、麦冬10-15份、玄参10-15份、川贝母10-20份、丹皮10-15份、白芍10-20份、薄荷10-15份、黄连8-15份、黄芩10-20份、大黄6-12份、甘草6-9份。
作为优选地,该中药组合物由以下重量份的原料组成生地12份、麦冬11 份、玄参11份、川贝母12份、丹皮11份、白芍12份、薄荷11份、黄连10 份、黄芩13份、大黄8份、甘草7份。
作为优选地,该中药组合物由以下重量份的原料组成:生地15份、麦冬 13份、玄参13份、川贝母15份、丹皮13份、白芍15份、薄荷13份、黄连 12份、黄芩15份、大黄9份、甘草8份。
作为优选地,该中药组合物由以下重量份的原料组成生地18份、麦冬14 份、玄参14份、川贝母18份、丹皮14份、白芍18份、薄荷14份、黄连13 份、黄芩18份、大黄11份、甘草8份。
本发明同时提供了一种如上所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地、麦冬、玄参、川贝母、丹皮、白芍、薄荷、黄连、黄芩、大黄、甘草,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后置于容器中用常温水浸泡60-100 分钟;
2)、将浸泡后的中药原料和浸泡用的水置于砂锅中,武火煮沸后,文火加热30分钟,晾至温度降至50-70℃后,取滤液,砂锅中的药渣备用,并将滤液倒入容器中;
3)、将步骤2)中砂锅中的药渣中加入热水,进行二次煎煮,先武火煮沸,再文火煮20分钟,晾至温度降至50-70℃后,滤得二次药液;
4)、将步骤2)和步骤3)中得到的药液合并,并混合均匀,晾至室温后装瓶或装袋,得中药组合物药液。
上述方法制备的为中药汤剂,本中药汤剂的服用方法为:1天分三次服用。也可1次性煎煮2天的药量,将制得的药液杀菌后灌装密封,冷藏,服用时先微加热即可。本中药组合物还可以制备成粉剂胶囊,具体方案如下:
如上所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地、麦冬、玄参、川贝母、丹皮、白芍、薄荷、黄连、黄芩、大黄、甘草,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后研磨成粉,过500-800目筛分后,得中药粉末;
2)、将步骤1)得到的中药粉末装入胶囊皮中制成中药胶囊。
进一步地,该制备方法1)步骤中得到的中药粉末的粒度为600目。
本发明的中药组合物无毒副作用,治疗效果好,标本兼治,不易复发,针对慢性咽炎,具有泻火散寒、清热止痛、清热止痛、滋阴降火的作用,对慢性咽炎具有很好的疗效,长期服用,可使慢性咽炎根除。
该中药组合物可以制备成中药片剂、颗粒、中药丸等多种形式,并不局限为汤剂和胶囊,适用于多种治疗方式,用药方式。
本发明中各类中药的药理如下:
生地:性味归经:甘,寒。归心,肝,肾经。功能主治:清热凉血,养阴,生津。用于热病舌绛烦渴,阴虚内热,骨蒸劳热,内热消渴,吐血,衄血,发斑发疹。
麦冬:麦冬味甘,微苦,性寒。入心、肺、胃三经。功能主治:滋阴润肺、益胃生津、清心除烦。现代医学认为麦冬具有强心、利尿、抗菌的作用。主治热病伤津、心烦、口渴、咽干、肺热燥咳、肺结核咯血、咽喉痛等症。可用于肺热干咳、咽干喉痛、痰中带血、便秘、胃痛、心烦、失眠等证的治疗。现代中药药理学证实,麦冬含多种甾体皂苷及氨基酸、葡萄糖、维生素A和B一谷甾醇、黏液质、钾、钠、钙、镁、锌、铬等。能增加冠脉流量,对心肌缺血有明显的保护作用,改善心肌收缩,降低心肌氧耗,抗心律失常,防治心血管疾病。此外,有一定的镇静、降血糖作用(可保护受损的胰岛细胞恢复,增加肝糖原),还有提高机体抗饥饿的能力、增强机体免疫力、延长抗体的时间、清除体内自由基而抗衰老的作用。
玄参:性味归经:甘、苦、咸,微寒。归脾、胃、肾经。功能主治:清热凉血;滋阴降火;解毒散结。温热病热和营血;身热;烦渴;舌绛;发斑;骨蒸劳嗽;虚烦不寤;津伤便秘;目涩昏花;咽喉喉肿痛;瘰疬痰核;痈疽疮毒。
川贝母:性味:苦、甘,微寒。归经:归肺、心经。清热润肺,化痰止咳。用于肺热燥咳,干咳少痰,阴虚劳嗽,咯痰带血。
丹皮:性味:苦、辛、寒。归经:入心、肝、肾经。功能:清热凉血,活血散瘀。主治:斑疹吐衄,血滞经闭,经前发热,痈肿疮毒,损伤瘀血、阴虚发热、无汗滑蒸。
临床应用:主要用于清泻肝火和凉血消瘀(消炎、降压)。
白芍:性味:苦、酸,微寒。入肝、脾经。具有补血柔肝、平肝止痛、敛阴收汗等功效,适用于阴虚发热、月经不调、胸腹胁肋疼痛、四肢挛急,泻痢腹痛、自汗盗汗、崩漏、带下等症。
薄荷:性味:辛,凉。归经:入肺、肝经。宣散风热,清头目,透疹。用于风热感冒,温病初起,头痛,目赤,喉痹,口疮,风疹,麻疹,胸胁涨闷。
黄连:性味归经:苦,寒。归心、脾、胃、肝、胆、大肠经。清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。
黄芩:性味归经:味苦,性寒。归肺、胆、脾、大肠、小肠经。功能主治:清热燥湿,泻火解毒,止血,安胎,降血压。用于湿温、暑温胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。
大黄:性味归经:苦,寒。胃经;大肠经;肝经;脾经。泻热通肠,凉血解毒,逐瘀通经。用于实热便秘,积滞腹痛,泻痢不爽,湿热黄疸,血热吐衄,目赤,咽肿,肠痈腹痛,痈肿疔疮,瘀血经闭,跌打损伤,外治水火烫伤;上消化道出血。酒大黄善清上焦血分热毒。用于目赤咽肿,齿龈肿痛。熟大黄泻下力缓,泻火解毒。用于火毒疮疡。大黄炭凉血化瘀止血。用于血热有瘀出血症。
甘草:性味归经:甘,平。入脾、胃、肺经。治五脏六腑寒热邪气,坚筋骨,长肌肉,倍气力,解毒,久服轻身延年。生用泻火热,熟用散表寒,去咽痛,除邪热,缓正气,养阴血,补脾胃,润肺。生甘草,长于清火,以清热解毒,润肺止咳力胜。用于痰热咳嗽,咽喉肿痛等。炙甘草,长于温中,以甘温益气,缓急止痛力强。用于脾虚胃弱,心悸脉结代等。粉甘草,善治尿道痛,尿路淋,生草节宜消肿毒、利关节;粉甘草,偏重清内热,泻心火。同是一物,其炮制所不同,则功效主治亦别。
目前已公认“整体观念”、“辨证施治”、“复方使用”、“复方配伍用药如用兵”是中医最科学最有效的几大优势,其中“复方配伍用药如用兵”是非常科学的中医药原创理论。中医组方中各药如行兵布阵那样环环相扣的严密配伍,是其优于西药配方的有效手段。中医方剂理论认为,每一方剂,不仅需要根据病因病机选择合适的药物妥善配伍,同时也应该符合方剂的基本结构,即“君、臣、佐、使”的组方配伍理论,所谓“君、臣、佐、使”的组方配伍,就是其建立在对疾病病机的全方位判断基础上的科学配比。中医用方通过多环节、多靶点整合调节的生物学机制,可以取得比西药更持久、更绿色天然无毒副作用的治疗效果,而这种疗效是建立在上述中医传统原创理论的正确指导之上的,本发明正遵循了这一原则。
君药是指方中治疗主症,起主要治疗作用的药物,按照需要可用一味或几味药。臣药是协助主药或加强主药功效的药物。佐药是协助主药治疗兼症或抑制主药的毒性的药物。使药是引导各药直达病变部位或调和各药的作用。
本发明以清热凉血、养阴生津的生地为君药,以滋阴润肺的麦冬和滋阴降火的玄参为臣药,以清热润肺的川贝母、清热凉血的丹皮、平肝止痛的白芍、宣散风热的薄荷、清热燥湿的黄连、泻火解毒的黄芩、以及逐瘀通经的大黄为佐药,以泻火散寒、清热止痛的甘草为使药,配伍合理,滋阴降火、清热润肺、宣散风热与寒湿、通经络、止痛,无毒副作用,对于各种原因引起的久治不愈的慢性咽炎,疗效好,见效快,标本兼治,治愈疗程短,不易复发,费用低廉。
具体实施方式
下面结合实施例对本发明进行进一步说明。
实施例一:
一种治疗慢性咽炎的中药组合物,其特征在于该中药由以下重量份的原料组成:生地10份、麦冬10份、玄参10份、川贝母10份、丹皮10份、白芍 10份、薄荷10份、黄连8份、黄芩10份、大黄6份、甘草6份。
本实施例同时公开了一种如上所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地10份、麦冬10份、玄参10份、川贝母10份、丹皮10份、白芍10份、薄荷10份、黄连8份、黄芩10份、大黄6份、甘草 6份,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后置于容器中用常温水浸泡60分钟;
2)、将浸泡后的中药原料和浸泡用的水置于砂锅中,武火煮沸后,文火加热30分钟,晾至温度降至50℃后,取滤液,砂锅中的药渣备用,并将滤液倒入容器中;
3)、将步骤2)中砂锅中的药渣中加入热水,进行二次煎煮,先武火煮沸,再文火煮20分钟,晾至温度降至50℃后,滤得二次药液;
4)、将步骤2)和步骤3)中得到的药液合并,并混合均匀,晾至室温后装瓶或装袋,得中药组合物药液。
实施例二
一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成:生地20份、麦冬15份、玄参15份、川贝母20份、丹皮15份、白芍20份、薄荷15份、黄连15份、黄芩20份、大黄12份、甘草9份。
本实施例同时提供了一种如上所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地20份、麦冬15份、玄参15份、川贝母20份、丹皮15份、白芍20份、薄荷15份、黄连15份、黄芩20份、大黄12份、甘草9份,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后研磨成粉,过500目筛分后,得中药粉末;
2)、将步骤1)得到的中药粉末装入胶囊皮中制成中药胶囊。
实施例三:
一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成:生地12份、麦冬11份、玄参11份、川贝母12份、丹皮11份、白芍12份、薄荷11份、黄连10份、黄芩13份、大黄8份、甘草7份。
本实施例同时提供了一种如上所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地12份、麦冬11份、玄参11份、川贝母12份、丹皮11份、白芍12份、薄荷11份、黄连10份、黄芩13份、大黄8份、甘草7份,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后置于容器中用常温水浸泡80分钟;
2)、将浸泡后的中药原料和浸泡用的水置于砂锅中,武火煮沸后,文火加热30分钟,晾至温度降至60℃后,取滤液,砂锅中的药渣备用,并将滤液倒入容器中;
3)、将步骤2)中砂锅中的药渣中加入热水,进行二次煎煮,先武火煮沸,再文火煮20分钟,晾至温度降至60℃后,滤得二次药液;
4)、将步骤2)和步骤3)中得到的药液合并,并混合均匀,晾至室温后装瓶或装袋,得中药组合物药液。
实施例四:
一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成:生地15份、麦冬13份、玄参13份、川贝母15份、丹皮13份、白芍15份、薄荷13份、黄连12份、黄芩15份、大黄9份、甘草8份。
本实施例同时提供了一种如上所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地15份、麦冬13份、玄参13份、川贝母15份、丹皮13份、白芍15份、薄荷13份、黄连12份、黄芩15份、大黄9份、甘草8份,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后研磨成粉,过600目筛分后,得中药粉末;
2)、将步骤1)得到的中药粉末装入胶囊皮中制成中药胶囊。
实施例五:
一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成:生地18份、麦冬14份、玄参14份、川贝母18份、丹皮14份、白芍18份、薄荷14份、黄连13份、黄芩18份、大黄11份、甘草8份。
本实施例同时提供了一种如上所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地18份、麦冬14份、玄参14份、川贝母18份、丹皮14份、白芍18份、薄荷14份、黄连13份、黄芩18份、大黄11份、甘草8份,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后置于容器中用常温水浸泡80分钟;
2)、将浸泡后的中药原料和浸泡用的水置于砂锅中,武火煮沸后,文火加热30分钟,晾至温度降至70℃后,取滤液,砂锅中的药渣备用,并将滤液倒入容器中;
3)、将步骤2)中砂锅中的药渣中加入热水,进行二次煎煮,先武火煮沸,再文火煮20分钟,晾至温度降至70℃后,滤得二次药液;
4)、将步骤2)和步骤3)中得到的药液合并,并混合均匀,晾至室温后装瓶或装袋,得中药组合物药液。
本发明同时以实施例1所给出的数据进行了临床疗效追踪,疗效汇总如下:
1.选慢性咽炎患者100例,年龄15-65岁,平均年龄46岁,病程最长8 年,最低3年,将患者随机分为两组,治疗组50例,对照组50例,两组年龄等资料无显著性差异,具有可比性。其共同的典型症状为持续性咽干,反复咽痛,咳嗽,进食辛辣食物及情志不舒时加重;咽部充血,咽后壁滤泡增生。
2.治疗方法,治疗组口服本发明优选配方实施例1制得的中药组合物,每日分早晚两次服用,疗程25天。对照组口服一般治疗用西药每天按剂量和次数服用,疗程25天。
3.诊断标准
所有病例均符合国家中医药管理局颁发的《中医病证诊断标准》中的诊断标准。
治愈:患者症状和体征全部消失;
显效:患者大部分症状和体征消失,咽干、咽痛、咳嗽症状减少90%;
有效:患者症状、体征均有改善,咽干、咽痛、咳嗽症状减少50%;
无效:患者症状无改善,检查结果显示病情无变化或有进展。
4.治疗结果,治疗组的治愈率为67%,显效13%,有效10%,无效10%,总有效率90%;对照组的治愈率为34%,显效18%,有效22%,无效26%,总有效率74%。治疗组所有患者随访一个月,均未发现复发迹象。
本发明的中药进行了毒性试验,试验效果如下:
选取体重相当的成年雌、雄小白鼠各20只,分为对照组和给药组,饲养条件一致,对照组不喂药,给药组每天喂药1次,每天记录各个小白鼠的身体状况、摄食、饮水、体重,试验持续六个月,与对照组相比,给药组小白鼠身体状况、摄食、饮水、体重增长均正常,且未见小白鼠生病或死亡。提示该药安全性好,无毒副作用。
本发明的中药的治疗案例如下:
案例一,江某,男,26岁。咽痛、咽干、声音嘶哑三年,使用过各种治疗慢性咽炎的药物,不是效果差就是停药立即复发,无意间得知发明人治疗慢性咽炎的信息,到发明人所在的中医门诊就诊,给予本发明提供的中药,一周后,症状明显减轻,两周后不再声音嘶哑、咽痛,三周后咽干也消失了,基本治愈,为巩固治疗,又服药一周。至今未复发。
案例二,李某,女,42岁。咽干、咽痒、咽痛、发音困难,被诊断为慢性咽炎,采用西药治疗3个月,无明显好转,考虑到西药毒副作用大且容易使细菌产生抗药性,来到发明人所在的中医门诊问诊,给予本发明提供的中药,一周后不再咽痒,两周后咽干咽痛明显减轻,能够顺利发声,三周后咽干咽痛基本消失,又用药一周,咽干咽痛完全消失,痊愈。至今未复发。
案例三,张某,女,31岁,高中寄校学习期间,饮食不规律,过冷,过辣的食物常吃,作息不规律,得慢性咽炎,大学期间虽有治疗,但是好转一端时间又犯,特别是季节转换过程中,经常咽痛、咳嗽,夜间加重,毕业后参加工作期间,咽炎导致的咽痛、咳嗽已经严重影响到了她的生活和工作,特别是工作紧张时加重,曾服用多种抗炎药物(具体不详)不见好转。要求服中草药治疗,服用本发明的中药组合物产品后,一周后明显好转,晚上能安睡,白天谈一天业务,说一天话也不会非常痛,继续服用两个月后,痊愈,随访至今,无复发。
案例四,刘某,男,58岁,患慢性咽炎十余年,白天夜晚从未间断,冬季厉害,经检查,咽部充血,咽后壁滤泡增生。辨证为肺肾阴虚。给予本方药治疗一疗程诸症消失,又服20天巩固治疗,随访至今,未再复发。
案例五,赵某,女,43岁,某公司管理人员,慢性咽炎患者,长期出差,作息不规律,应酬饮酒后咽痛、咽干、咳嗽加重,服用咽炎片及利咽颗粒等药物只能减轻,不能根治,而且容易复发,其咽部红肿充血,咽后壁有滤泡增生,舌红苔薄白,脉弦细,诊为肺肾两虚型慢性咽炎。给予本发明的中药组合物相关产品一周后症状大减,继服30天,诸症消失痊愈,随访至今,再未复发。
可以理解的是,以上关于本发明的具体描述,仅用于说明本发明而并非受限于本发明实施例所描述的技术方案,本领域的普通技术人员应当理解,仍然可以对本发明进行修改或等同替换,以达到相同的技术效果;只要满足使用需要,都在本发明的保护范围之内。
Claims (7)
1.一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成:生地10-20份、麦冬10-15份、玄参10-15份、川贝母10-20份、丹皮10-15份、白芍10-20份、薄荷10-15份、黄连8-15份、黄芩10-20份、大黄6-12份、甘草6-9份。
2.根据权利要求1所述的一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成生地12份、麦冬11份、玄参11份、川贝母12份、丹皮11份、白芍12份、薄荷11份、黄连10份、黄芩13份、大黄8份、甘草7份。
3.根据权利要求1所述的一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成:生地15份、麦冬13份、玄参13份、川贝母15份、丹皮13份、白芍15份、薄荷13份、黄连12份、黄芩15份、大黄9份、甘草8份。
4.根据权利要求2所述的一种治疗慢性咽炎的中药组合物,其特征在于该中药组合物由以下重量份的原料组成生地18份、麦冬14份、玄参14份、川贝母18份、丹皮14份、白芍18份、薄荷14份、黄连13份、黄芩18份、大黄11份、甘草8份。
5.一种如权利要求1-4中任一项所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地、麦冬、玄参、川贝母、丹皮、白芍、薄荷、黄连、黄芩、大黄、甘草,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后置于容器中用常温水浸泡60-100分钟;
2)、将浸泡后的中药原料和浸泡用的水置于砂锅中,武火煮沸后,文火加热30分钟,晾至温度降至50-70℃后,取滤液,砂锅中的药渣备用,并将滤液倒入容器中;
3)、将步骤2)中砂锅中的药渣中加入热水,进行二次煎煮,先武火煮沸,再文火煮20分钟,晾至温度降至50-70℃后,滤得二次药液;
4)、将步骤2)和步骤3)中得到的药液合并,并混合均匀,晾至室温后装瓶或装袋,得中药组合物药液。
6.一种如权利要求1-4中任一项所述的治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法包括如下步骤:
1)、按重量份称取生地、麦冬、玄参、川贝母、丹皮、白芍、薄荷、黄连、黄芩、大黄、甘草,筛分除杂,较大的原料切成黄豆大小的小块,混合均匀后在紫外线灭菌灯下灭菌处理1小时,然后研磨成粉,过500-800目筛分后,得中药粉末;
2)、将步骤1)得到的中药粉末装入胶囊皮中制成中药胶囊。
7.根据权利要求6所述的一种治疗慢性咽炎的中药组合物的制备方法,其特征在于该制备方法1)步骤中得到的中药粉末的粒度为600目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711253634.8A CN107823424A (zh) | 2017-12-02 | 2017-12-02 | 一种治疗慢性咽炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711253634.8A CN107823424A (zh) | 2017-12-02 | 2017-12-02 | 一种治疗慢性咽炎的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107823424A true CN107823424A (zh) | 2018-03-23 |
Family
ID=61641035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711253634.8A Withdrawn CN107823424A (zh) | 2017-12-02 | 2017-12-02 | 一种治疗慢性咽炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107823424A (zh) |
-
2017
- 2017-12-02 CN CN201711253634.8A patent/CN107823424A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
CN103110730B (zh) | 一种治疗哮喘的苏子芩杏汤剂及其制备方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN101766787B (zh) | 治疗高热、咳喘的灌肠液 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN105497723A (zh) | 一种治疗细菌性肺炎的中药制剂及其制备方法 | |
CN106334171B (zh) | 一种用于修复肝损伤的中药制剂及制备方法 | |
CN104706976A (zh) | 一种治疗失眠的益气安神中药剂及制备方法 | |
CN103989762B (zh) | 一种清热泻腑止咳化痰的中药组合物及其制备方法 | |
CN105998840A (zh) | 一种用于治疗虫咬皮炎的外用药膏及制备方法 | |
CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN107823424A (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
CN106334155A (zh) | 一种治疗动甲状腺肿大的中药组合物及其制备方法 | |
CN105168847A (zh) | 一种用于治疗幽门螺杆菌感染性消化性溃疡的中药 | |
CN106806762A (zh) | 一种治疗多痰性支气管扩张症的中药制剂及其制备方法 | |
CN105168838A (zh) | 一种治疗咽喉炎的中药组合物及其制剂 | |
CN104586998A (zh) | 一种治疗急性胆囊炎的中药制剂及其制备方法 | |
CN104524149A (zh) | 一种防治急性肾炎的药物组合物及其应用 | |
CN113855778A (zh) | 一种治疗脾肾阳衰顽痰痼血型食管癌的中药 | |
CN103041259B (zh) | 治疗小儿痰多咳嗽呼吸道感染的中药制剂 | |
CN108042701A (zh) | 一种治疗复发性口疮的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180323 |
|
WW01 | Invention patent application withdrawn after publication |